相似文献
1
Characterization of Neisseria meningitidis strains causing disease in complement-deficient and complement-sufficient patients.
J Clin Microbiol. 1998 Aug;36(8):2342-5. doi: 10.1128/JCM.36.8.2342-2345.1998.
2
Characterization of strains of Neisseria meningitidis recovered from complement-sufficient and complement-deficient patients in the Western Cape Province, South Africa.
J Clin Microbiol. 1994 Sep;32(9):2185-91. doi: 10.1128/jcm.32.9.2185-2191.1994.
3
Assessment of complement deficiency in patients with meningococcal disease in The Netherlands.
Clin Infect Dis. 1999 Jan;28(1):98-105. doi: 10.1086/515075.
4
Characterization of Neisseria meningitidis isolates and clinical features of meningococcal conjunctivitis in ten patients.
Eur J Clin Microbiol Infect Dis. 1994 May;13(5):388-93. doi: 10.1007/BF01971995.
5
Increase in moderate penicillin resistance and serogroup C in meningococcal strains isolated in Spain. Is there any relationship?
Clin Infect Dis. 1994 Feb;18(2):161-5. doi: 10.1093/clinids/18.2.161.
6
Phenotypic and genotypic approaches to characterization of isolates of Neisseria meningitidis from patients and their close family contacts.
J Clin Microbiol. 2001 Apr;39(4):1235-40. doi: 10.1128/JCM.39.4.1235-1240.2001.
7
Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001.
Can J Microbiol. 2003 Oct;49(10):633-8. doi: 10.1139/w03-074.
8
Molecular characterization of a collection of Neisseria meningitidis isolates from Croatia, June 2009 to January 2014.
J Med Microbiol. 2016 Sep;65(9):1013-1019. doi: 10.1099/jmm.0.000320. Epub 2016 Jul 22.
9
Irish strains of Neisseria meningitidis: characterisation using multilocus sequence typing.
Br J Biomed Sci. 2003;60(4):204-9. doi: 10.1080/09674845.2003.11783700.
10
Characterization of Neisseria meningitidis serogroup A strains from an outbreak in France by serotype, serosubtype, multilocus enzyme genotype and outer membrane protein pattern.
Eur J Clin Microbiol Infect Dis. 1991 May;10(5):405-9. doi: 10.1007/BF01968019.
引用本文的文献
1
The first case report of complement component 7 deficiency in Qatar and a 10-year follow-up.
Front Immunol. 2023 Oct 11;14:1253301. doi: 10.3389/fimmu.2023.1253301. eCollection 2023.
2
Meningococcal disease and the complement system.
Virulence. 2014 Jan 1;5(1):98-126. doi: 10.4161/viru.26515. Epub 2013 Oct 8.
3
Soluble CD59 expressed from an adenovirus in vivo is a potent inhibitor of complement deposition on murine liver vascular endothelium.
PLoS One. 2011;6(6):e21621. doi: 10.1371/journal.pone.0021621. Epub 2011 Jun 24.
4
A non membrane-targeted human soluble CD59 attenuates choroidal neovascularization in a model of age related macular degeneration.
PLoS One. 2011 Apr 28;6(4):e19078. doi: 10.1371/journal.pone.0019078.
5
Infections of people with complement deficiencies and patients who have undergone splenectomy.
Clin Microbiol Rev. 2010 Oct;23(4):740-80. doi: 10.1128/CMR.00048-09.
本文引用的文献
1
Recurrent meningococcal septicaemia and properdin deficiency.
J Infect. 1995 Jul;31(1):67-8. doi: 10.1016/s0163-4453(95)91550-8.
2
Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis.
J Infect Dis. 1993 Jun;167(6):1320-9. doi: 10.1093/infdis/167.6.1320.
3
Meningococcal disease in The Netherlands, 1958-1990: a steady increase in the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis.
Clin Infect Dis. 1993 Feb;16(2):237-46. doi: 10.1093/clind/16.2.237.
4
Complement deficiency states and meningococcal disease.
Immunol Res. 1993;12(3):295-311. doi: 10.1007/BF02918259.
5
Meningococcal disease in patients with late complement component deficiency: studies in the U.S.S.R.
Medicine (Baltimore). 1993 Nov;72(6):374-92. doi: 10.1097/00005792-199311000-00002.
6
Phenotypic and genotypic changes in a new clone complex of Neisseria meningitidis causing disease in The Netherlands, 1958-1990.
J Infect Dis. 1994 Mar;169(3):673-6. doi: 10.1093/infdis/169.3.673.
7
Characterization of strains of Neisseria meningitidis recovered from complement-sufficient and complement-deficient patients in the Western Cape Province, South Africa.
J Clin Microbiol. 1994 Sep;32(9):2185-91. doi: 10.1128/jcm.32.9.2185-2191.1994.
8
Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency.
Medicine (Baltimore). 1984 Sep;63(5):243-73.
9
Meningococcal carriage in a population of "normal" families.
J Infect Dis. 1971 Jan;123(1):67-73. doi: 10.1093/infdis/123.1.67.
10
Natural serum bactericidal activity against Neisseria meningitidis isolates from disseminated infections in normal and complement-deficient hosts.
J Infect Dis. 1985 Dec;152(6):1332-5. doi: 10.1093/infdis/152.6.1332.
Zotero 插件